ストックスクリーナーアプリを入手
1.42
0.00%
0.00
前日終値:
$1.42
開ける：
$1.4199
24時間の取引高:
9,172
Relative Volume:
0.18
時価総額：
$9.25M
収益：
$5.64M
当期純損益:
$-23.88M
株価収益率:
-2.6792
EPS:
-0.53
ネットキャッシュフロー:
$-22.36M
1週間 パフォーマンス:
-3.07%
1か月 パフォーマンス:
-14.46%
6か月 パフォーマンス:
-60.77%
1年 パフォーマンス:
-83.86%
1日の値動き範囲:
$1.405
$1.42
1週間の範囲:
$1.37
$1.47
52週間の値動き範囲:
$1.20
$10.40
Evogene Ltd Stock (EVGN) Company Profile
EVGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.42 | 9.25M | 5.64M | -23.88M | -22.36M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.98 | 123.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
707.46 | 79.09B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
627.86 | 37.97B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
249.85 | 31.74B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
259.44 | 27.71B | 3.32B | -860.46M | -1.04B | -8.32 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-10-08 | 開始されました | ROTH Capital | Buy |
| 2021-07-29 | 開始されました | Aegis Capital | Buy |
| 2020-12-01 | 開始されました | Cantor Fitzgerald | Overweight |
| 2013-12-16 | 開始されました | Oppenheimer | Outperform |
Evogene Ltd (EVGN) 最新ニュース
StockNews.com Initiates Coverage on Evogene (NASDAQ:EVGN) - Armenian Reporter
Evogene (NASDAQ:EVGN) Now Covered by StockNews.com - Defense World
Evogene Schedules Fourth Quarter 2024 Financial Results Release - Krishak Jagat English
StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN) - Defense World
AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease - PR Newswire
Revolutionary Discovery: New Weapon Against €1.2B Wheat Disease Threat Unveiled - StockTitan
Evogene Shareholders Approve Key Proposal in Special Meeting - TipRanks
SEC Form 424B3 filed by Evogene Ltd - Quantisnow
Evogene (NASDAQ:EVGN) Coverage Initiated by Analysts at StockNews.com - Armenian Reporter
Evogene Ltd. Reschedules Special General Meeting Due to Lack of Quorum - TipRanks
Evogene (NASDAQ:EVGN) Now Covered by Analysts at StockNews.com - Defense World
United States Agricultural Biologicals Market Competition - GlobeNewswire
United States Agricultural Biologicals Market Competition and Forecasts 2024-2029, Competitive Analysis of BASF, Syngenta Crop Protection, Bayer, Evogene ,Vegalab Inc. - Yahoo Finance
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting - GuruFocus.com
Monsanto Expands Agreement with Israel’s Evogene - Agribusiness Global
Higher R&D costs lead Evogene to loss - גלובס
Evogene Ltd. Announces Conclusion of Employment of Eyal Ronen as Executive Vice President of Business Development, Effective March 4, 2025 - Marketscreener.com
Evogene Announces Management Restructuring - TipRanks
Evogene Announces Special General Meeting to Approve Share Options for CEO - TipRanks
Lavie Bio Announces Expansion of its Bio-Inoculant Product for S - GuruFocus.com
Evogene (NASDAQ:EVGN) Earns Sell Rating from Analysts at StockNews.com - Defense World
N2OFF (NASDAQ:NITO) and Evogene (NASDAQ:EVGN) Head-To-Head Review - Defense World
Evogene Ltd. (NASDAQ:EVGN) Position Lessened by BNP Paribas Financial Markets - Defense World
Evogene (NASDAQ:EVGN) vs. N2OFF (NASDAQ:NITO) Financial Review - Defense World
Evogene stock touches 52-week low at $1.25 amid market challenges - Investing.com Canada
Evogene stock touches 52-week low at $1.25 amid market challenges By Investing.com - Investing.com South Africa
Minichromosomal Technology in Agriculture Market Size - openPR
Marrone Bio Innovations : Evogene and Marrone Bio Innovations Disclose Positive Results in Insect Control Collaboration - Marketscreener.com
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification - GuruFocus.com
Evogene Schedules Second Quarter 2024 Financial Results Release - The Eastern Progress Online
Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials - The Eastern Progress Online
Evogene stock touches 52-week low at $1.44 amid market challenges - Investing.com Nigeria
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024 - GuruFocus.com
Evogene Unit Receives Notice Of Termination Of Licensing Agreement With Corteva For Bio Fungicide Lead Candidates - XM
Evogene Q3 2024 Earnings Preview - MSN
Ventum Financial Issues Pessimistic Forecast for Evogene (TSE:EVGN) Stock Price - Defense World
Evogene Ltd. (NASDAQ:EVGN) Q3 2024 Earnings Call Transcript - Insider Monkey
Evogene Ltd (EVGN) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities - Investing.com Canada
Evogene Schedules Third Quarter 2024 Financial Results Release - GuruFocus.com
Casterra Announces a Key Milestone in its Operational Expansion - GuruFocus.com
Evogene Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Evogene earnings missed by $0.30, revenue fell short of estimates - Investing.com India
Evogene Reports Third Quarter 2024 Financial Results - The Malaysian Reserve
Evogene: Q3 Earnings Snapshot - San Antonio Express-News
Evogene Sees Revenue Growth and Expands AI Collaboration - TipRanks
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results - Marketscreener.com
Evogene Ltd (EVGN) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
2.78%
大文字化:
|
ボリューム (24 時間):